Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Metrics to compare | SBSd | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBSdPeersSector | |
---|---|---|---|---|
P/E Ratio | 22.3x | 21.4x | −0.5x | |
PEG Ratio | 4.88 | 0.12 | 0.00 | |
Price/Book | 1.5x | 2.2x | 2.6x | |
Price / LTM Sales | 1.4x | 1.7x | 3.2x | |
Upside (Analyst Target) | - | 34.2% | 41.7% | |
Fair Value Upside | Unlock | 22.4% | 6.1% | Unlock |